Antiphospholipids (aPLs) (aCLs, anti-beta2 glycoprotein I or LAC) are found in 2% to 6% of healthy individuals and have been associated with recurrent thromboembolism and fetal loss with APS. Here, LCT is linked to Thromboembolism.